Literature DB >> 15652988

The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

P S Sharp1, J R T Dick, L Greensmith.   

Abstract

Around 20% of familial cases of amyotrophic lateral sclerosis have been shown to carry mutations in Cu/Zn superoxide dismutase 1 (Cu/Zn SOD1). Transgenic mice over-expressing human mutant SOD1 genes have been developed and in this study we examined the effect of nerve injury on disease progression in these mice. Firstly, disease progression in uninjured mice was characterised using physiological methods. Muscle force, contractile characteristics and motor unit survival was established at 90 days, an early symptomatic stage and also at the end-stage of the disease, at 130 days. In addition, muscle histochemistry was examined and the extent of motoneuron survival established morphologically. By 90 days of age, there is a significant reduction in muscle force, and nearly 40% of motoneurons within the sciatic motor pool have already died. By 130 days, the muscles are significantly weaker, and there is a dramatic change in the phenotype of extensor digitorum longus (EDL), which changes from a fast fatigable muscle, to a fatigue resistant muscle with a high oxidative capacity. By this stage of the disease, only 40% of motor units in EDL survive, with only 29% of motoneurons surviving within the sciatic motor pool. Following injury to the sciatic nerve in SOD1(G93A) mice, there is an acceleration in disease progression so that 90 day old mice show deficits that are only seen at the end stage in uninjured SOD1(G93A) mice. It is therefore possible that mutant SOD1 toxicity increases the vulnerability of motoneurons and muscles to stressful stimuli such as nerve injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652988     DOI: 10.1016/j.neuroscience.2004.09.069

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  33 in total

1.  Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.

Authors:  Paul S Sharp; Hema Bye-a-Jee; Dominic J Wells
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  Clinically definite ALS presenting weeks after mild electric injury: causality or coincidence?

Authors:  Abdullah Al-Ajmi; Rossen T Rousseff; Adnan J Khuraibet
Journal:  Neurol Sci       Date:  2012-01-07       Impact factor: 3.307

3.  SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism.

Authors:  Susan E Smittkamp; Jill K Morris; Gregory L Bomhoff; Mark E Chertoff; Paige C Geiger; John A Stanford
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

4.  Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats.

Authors:  Angelo C Lepore; Christopher Tolmie; John O'Donnell; Megan C Wright; Christine Dejea; Britta Rauck; Ahmet Hoke; Anthony R Ignagni; Raymond P Onders; Nicholas J Maragakis
Journal:  Neurobiol Dis       Date:  2010-04-08       Impact factor: 5.996

5.  Delayed functional recovery in presymptomatic mSOD1G93A mice following facial nerve crush axotomy.

Authors:  Nichole A Mesnard; Melissa M Haulcomb; Lisa Tanzer; Virginia M Sanders; Kathryn J Jones
Journal:  J Neurodegener Regen       Date:  2013

6.  Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice.

Authors:  Dairín Kieran; Ina Woods; Andreas Villunger; Andreas Strasser; Jochen H M Prehn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

7.  Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.

Authors:  S E Smittkamp; J W Brown; J A Stanford
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

8.  Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Kevin H J Park; Inez Vincent
Journal:  Biochim Biophys Acta       Date:  2008-04-25

9.  Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1G37R ALS Mouse Model.

Authors:  Éric Martineau; Danielle Arbour; Joanne Vallée; Richard Robitaille
Journal:  J Neurosci       Date:  2020-08-28       Impact factor: 6.167

10.  A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis.

Authors:  Colin K Franz; Eric T Quach; Christina A Krudy; Thais Federici; Michele A Kliem; Brooke R Snyder; Bethwel Raore; Nicholas M Boulis
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.